Patent · US Active

Anti-CTLA-4 antibodies

US11267887B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 13, 2017
Grant dateMar 8, 2022
Priority date—
Expiry dateAug 29, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/574
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anti-CTLA-4 antibodies are disclosed. Also disclosed are compositions comprising such antibodies, and uses and methods using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.